Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
P/S ratio for Amphastar Pharmaceuticals (AMPH)
P/S ratio as of April 2024 (TTM): 3.12
According to Amphastar Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.11784. At the end of 2023 the company had a P/S ratio of 4.60.
P/S ratio history for Amphastar Pharmaceuticals from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.60 | 69.43% |
| 2022 | 2.71 | 6.61% |
| 2021 | 2.55 | -6.76% |
| 2020 | 2.73 | -2.05% |
| 2019 | 2.79 | -11.5% |
| 2018 | 3.15 | -14.49% |
| 2017 | 3.68 | 10.85% |
| 2016 | 3.32 | 29.93% |
| 2015 | 2.56 | 3.83% |
| 2014 | 2.46 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | 2.07 | -33.69% | 🇺🇸 USA |
 SCYNEXIS SCYX | 0.4176 | -86.61% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | 2.49 | -20.12% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | 0.1400 | -95.51% | 🇺🇸 USA |